Literature DB >> 8255652

Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.

U E Pazzaglia1, G Beluffi, A Ravelli, G Zatti, A Martini.   

Abstract

A child with myositis ossificans progressiva was treated for 8 years with ethane-1-hydroxy-1,1-diphosphonate (EHDP) 30-40 mg/kg per day. Latterly he complained of severe, progressive bone and joint pain which made standing and walking almost impossible. A radiographic skeletal survey showed diffuse ricket-like lesions. Withdrawal of EHDP therapy produced substantial improvement in his general condition as well as in the radiographic appearance of the bones. Multiple exostoses were observed in this case and, particularly those around the knees, presented a peculiar morphology. This supports the theory that exostoses originate from a defect of metaphyseal modelling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255652     DOI: 10.1007/bf02012453

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  13 in total

1.  Radiographic findings in hereditary multiple exostoses and a new theory of the pathogenesis of exostoses.

Authors:  U E Pazzaglia; L Pedrotti; G Beluffi; V Monafò; S Savasta
Journal:  Pediatr Radiol       Date:  1990

2.  Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva.

Authors:  J G Rogers; J P Dorst; W B Geho
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

3.  Diphosphonate therapy in a patient with myositis ossificans progressiva.

Authors:  I W Weiss; L Fisher; J M Phang
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

4.  Editorial: Diphosphonate treatment in bone disease.

Authors:  H Fleisch; J P Bonjour
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

5.  Fibrodysplasia ossificans progressiva. An 11-year-old boy treated with a diphosphonate.

Authors:  L Bruni; P Giammaria; M C Tozzi; D Camparcola; F Scopinaro; C Imperato
Journal:  Acta Paediatr Scand       Date:  1990-10

6.  Fibrodysplasia ossificans progressiva. A survey of forty-two cases.

Authors:  J G Rogers; W B Geho
Journal:  J Bone Joint Surg Am       Date:  1979-09       Impact factor: 5.284

7.  Epi- and metaphyseal changes in children caused by administration of bisphosphonates.

Authors:  E L van Persijn van Meerten; H M Kroon; S E Papapoulos
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

8.  Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.

Authors:  R Smith; R G Russell; C G Woods
Journal:  J Bone Joint Surg Br       Date:  1976-02

9.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

10.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.